The head of the Department of Health and Human Services has spent decades promoting vaccine skepticism and has now revamped the US childhood immunization schedule to have one-third fewer recommended ...

If it feels like everyone is getting the flu, you're not imagining it. This is shaping up to be another severe flu season. That's why it's important to take advantage of every tool we have to keep the ...

Background: Cardiovascular disease caused by atherosclerosis is responsible for 18 million deaths annually, highlighting a significant need for new medical therapies, especially for patients who are ...

Tumor immunotherapies, especially those leveraging T cells to identify and eliminate cancer cells, represent a major breakthrough in cancer treatment. However, many tumor-associated antigens are too ...

Vaccines are an important part of medical care because they can protect you from future illness or can make the severity of the illness much less serious. There are six types. Vaccination is the ...

In 1986, a typical child was recommended to receive 11 vaccine doses — seven injections and four oral. Today, that number has risen to 50 to 54 doses by age 18, depending on whether one or two flu ...

ROS are key players in the immune system's response to infection and cancer, influencing how the body identifies and fights these threats. A balanced level of ROS supports healthy immune function, but ...

A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of life had reduced risk of developing a peanut allergy compared with children ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

A new study shows how pathogens control changes in their cell surface to evade the immune system. A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to ...

A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system. The immune system responds to an infection by producing antibodies that ...

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret antigens that could form the backbone of off-the-shelf immunotherapies.